UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*MACKENZIE ALEXANDER R

(Last)

(First)

(Middle)

PFIZER INC.-CORP. SECRETARY

235 EAST 42ND ST.

(Street)

NEW YORK

NY

10017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

06/23/2016

3. Issuer Name and Ticker or Trading Symbol

PFIZER INC

[ PFE ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

Executive Vice President

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common Stock

152,244

Common Stock

8,475

By Rule 16b-3 Plan

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (right to buy)

02/22/2010

02/21/2017

Common Stock

30,000

$25.87

Phantom Stock Units SSP

(1)

(1)

Common Stock

3,790

(2)

Stock Appreciation Rights

02/24/2018(3)

02/24/2018(3)

Common Stock

39,555

$18.9

Stock Appreciation Rights

02/23/2019(3)

02/23/2019(3)

Common Stock

41,615

$21.03

Stock Appreciation Rights

02/28/2020(3)

02/28/2020(3)

Common Stock

37,934

$27.37

Stock Appreciation Rights

02/25/2023(3)

02/25/2023(3)

Common Stock

31,972

$30.59

Stock Appreciation Rights

02/27/2021(3)

02/27/2021(3)

Common Stock

28,347

$32.23

Stock Appreciation Rights

02/26/2022(3)

02/26/2022(3)

Common Stock

27,852

$34.59

Explanation of Responses:

1. These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

2. Each unit represents one phantom share of common stock.

3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Remarks:

poarm16.htm

Susan E. Grant, by power of atty., for Alexander R. MacKenzie

06/30/2016

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.